IAS — Integral Ad Science Holding Income Statement
0.000.00%
Last trade - 00:00
- $1.55bn
- $1.58bn
- $474.37m
- 75
- 37
- 36
- 47
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 213 | 241 | 324 | 408 | 474 |
Cost of Revenue | |||||
Gross Profit | 180 | 200 | 269 | 333 | 375 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 247 | 255 | 360 | 386 | 457 |
Operating Profit | -33.8 | -13.9 | -36.7 | 22.1 | 17.1 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -66.8 | -45.5 | -56 | 13.1 | 4.86 |
Provision for Income Taxes | |||||
Net Income After Taxes | -51.3 | -32.4 | -52.4 | 15.4 | 7.24 |
Net Income Before Extraordinary Items | |||||
Net Income | -51.3 | -32.4 | -52.4 | 15.4 | 7.24 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -51.3 | -32.4 | -52.4 | 15.4 | 7.24 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.341 | -0.217 | -0.26 | 0.03 | 0.069 |
Dividends per Share |